SiPH Collaborates with IBM to Enhance Pathology Information System with Computational Advances and AI to Support Patients in Thailand and ASEAN

November 19, 2024 08:07 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

BANGKOK, Nov. 19, 2024 /PRNewswire/ -- Siriraj Piyamaharajkarun Hospital (SiPH), operating under Faculty of Medicine Siriraj Hospital, today announced a successful transformation of its Pathology Information System (PIS) using advanced computational technologies and artificial intelligence. In collaboration with IBM (NYSE: IBM), the system now integrates laboratory workflows, image scanning systems, and centralized data processing, establishing a cohesive approach for pathological cancer diagnosis and laying the foundation for SiPH's future advancements in cancer diagnostics.

SiPH and IBM team to bring to computational advances and AI to enhance Pathology Information System (PIS)
SiPH and IBM team to bring to computational advances and AI to enhance Pathology Information System (PIS)

Developed by IBM Supply Chain Industry 4.0 team in Singapore, the system simplifies data entry using smart forms and speech-to-text AI models, seamlessly integrating tissue specimen information with high-resolution images from slide scanners. These images undergo AI-powered analysis using algorithms from SiPH and AI inferencing capabilities of IBM Power10 MMA. This streamlined process gives pathologists real-time access to integrated data, allowing them to quickly and accurately diagnose potential cancer cases.

SiPH's newly transformed PIS system now empowers pathologists to focus on critical aspects of cancer diagnosis. The system's automated workflows and AI-driven slide image analysis—currently piloted for prostate cancer—streamlines the identification of potential cancerous tissues. By automatically processing and feeding diagnostic results back into the system, the platform enables doctors to concentrate on high-risk cases, significantly improving diagnostic accuracy and efficiency.

"The collaboration between SiPH and IBM reflects our commitment to delivering excellent clinical care for patients in Thailand and ASEAN. Today's success in transforming our pathology workflows and enhancing diagnostic quality will ultimately lead to more accurate cancer diagnostics, benefiting patients across Thailand and ASEAN," said Dr. Pornsuk Cheunsuchon, Director of Digital Pathology Center, SiPH. "This achievement also unlocks new capabilities in computational pathology, paving the way for integrated, automated AI-powered diagnostics to play a pivotal role in the future of clinical care at SiPH."

"IBM, together with our business partner SDC who implemented infrastructure systems, and Rax Interdiagnostic, are proud to have supported SiPH with platforms designed for AI inferencing workloads, seamless automation, and integrated pathology workflows, along with IBM Storage Scale's data and slide image storage solutions that enable capacity planning and forecasting," said Anothai Wettayakorn, Managing Director of IBM Thailand. "This advancement addresses key challenges in computational pathology, from integrating raw data from various sources to overcoming the limitations of processing power needed to analyze vast amounts of data and images. In particular, IBM Power 10's 99.9999% availability, the MMA in-built on-chip accelerator, together with end-to-end security, will help SiPH minimize risks, secure AI workloads at all layers, and protect data through accelerated encryption."

"Today's collaboration is a testament to a growing preference for technologies that offer speed, efficiency, transparency, and accuracy in healthcare, which will ensure better care for patients across Thailand and ASEAN," added Anothai.

About SiPH
Siriraj Piyamaharajkarun Hospital (SiPH), operating under the Faculty of Medicine Siriraj Hospital, is the first Joint Commission International (JCI) accredited public hospital in Thailand. SiPH is committed to providing medical services with moral, ethical, and dedicated care from highly service-minded personnel, serving as a model for government hospitals to operate with a specialized management system.

About IBM
IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM's hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM's breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM's long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.

Media Contact
Paranee Reymondon
External Relations Leader, IBM ASEAN
Email: [email protected]

Automated workflows system and AI-driven slide image analysis, currently piloted for prostate cancer
Automated workflows system and AI-driven slide image analysis, currently piloted for prostate cancer

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.